Nkarta (NKTX) Treasury Shares (2019 - 2026)
Nkarta's (NKTX) quarterly Treasury Shares came in at $1.0 million in Q1 2026, up 17.71% year-on-year from $854884.0 in Q1 2025, and up 55.06% quarter-over-quarter from $648959.0 in Q4 2025.
Nkarta (NKTX) Treasury Shares (2019 - 2026) Analysis & Trends
Nkarta's Treasury Shares history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- On a quarterly basis, Treasury Shares rose 17.71% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 17.71% increase from a year earlier, with the FY2025 full-year figure at $648959.0, down 44.43% from the prior year.
- Treasury Shares advanced to $1.0 million in Q1 2026 per NKTX's latest filing, from $648959.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q1 2024 and bottomed at $229418.0 in Q1 2022.
- The 5-year median for Treasury Shares is $716956.0 (2023), against an average of $755077.1.
- Across the five-year window, Treasury Shares jumped 1047.21% in 2022 and sank 44.43% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $356728.0 in 2022, then surged by 66.73% to $594768.0 in 2023, then soared by 96.36% to $1.2 million in 2024, then sank by 44.43% to $648959.0 in 2025, then soared by 55.06% to $1.0 million in 2026.
- Per Business Quant, the three latest NKTX Treasury Shares figures stand at $1.0 million (Q1 2026), $648959.0 (Q4 2025), and $661636.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 648,959.00 |
| Dec 31, 2025 | 648,959.00 |
| Sep 30, 2025 | 661,636.00 |
| Sep 30, 2025 | 661,636.00 |
| Jun 30, 2025 | 832,299.00 |
| Jun 30, 2025 | 832,299.00 |
| Mar 31, 2025 | 854,884.00 |
| Mar 31, 2025 | 854,884.00 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 594,768.00 |
| Dec 31, 2023 | 594,768.00 |